Stockscreener 앱 받기
3.10
4.32%
-0.14
시간 외 거래:
3.10
전일 마감가:
$3.24
열려 있는:
$3.3
하루 거래량:
77,481
Relative Volume:
1.98
시가총액:
$5.08M
수익:
-
순이익/손실:
$-36.46M
주가수익비율:
-1.2917
EPS:
-2.4
순현금흐름:
$-30.20M
1주 성능:
-22.50%
1개월 성능:
-27.74%
6개월 성능:
+75.64%
1년 성능:
-26.54%
1일 변동 폭
$3.0801
$3.38
1주일 범위
$3.0801
$3.9984
52주 변동 폭
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
명칭
Alaunos Therapeutics Inc
전화
(346) 355-4099
주소
2617 BISSONNET ST, HOUSTON
TCRT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
3.10 | 6.56M | 0 | -36.46M | -30.20M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-04 | 재개 | Wells Fargo | Overweight |
Alaunos Therapeutics Inc 주식(TCRT)의 최신 뉴스
What drives Alaunos Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - Autocar Professional
Alaunos Therapeutics Inc. Stock Analysis and ForecastHigh-impact stock picks - PrintWeekIndia
Is Alaunos Therapeutics Inc. a good long term investmentMarket-crushing stock picks - Autocar Professional
What analysts say about Alaunos Therapeutics Inc. stockUnprecedented profit potential - jammulinksnews.com
why alaunos therapeutics inc. stock attracts strong analyst attentionCapital Preservation Investment Ideas - Newser
Alaunos Therapeutics (NASDAQ:TCRT) Shares Up 0.3% – What’s Next? - Defense World
Alaunos Therapeutics appoints Michael A. Jerman to board and audit chair By Investing.com - Investing.com South Africa
Alaunos Therapeutics appoints Michael A. Jerman to board and audit chair - Investing.com
How Alaunos Therapeutics Inc. stock performs during market volatilityFree Exclusive Access to Stock Gurus - Newser
Why Alaunos Therapeutics Inc. stock attracts strong analyst attentionRapid Gain Targets - Newser
What makes Alaunos Therapeutics Inc. stock price move sharplySmart Growth Low Risk Picks - Newser
Alaunos Therapeutics Holds Annual Stockholders Meeting - MSN
Alaunos Therapeutics Secures $25M Equity Purchase Deal - MSN
Alaunos Therapeutics Appoints Holger Weis as New CEO - The Globe and Mail
Alaunos Therapeutics Raises $850,000 in Private Offering - TipRanks
Alaunos Therapeutics Closes Registered Direct Offering - TipRanks
Is Alaunos Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Alaunos Therapeutics stock slides on $2M equity offering - MSN
Alaunos Therapeutics raises $2 million in registered direct offering - Investing.com
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies - The Manila Times
PMGC Capital Urges Alaunos Therapeutics to Accept Strategic Financing Opportunity - Nasdaq
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) - GlobeNewswire
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading - Bluefield Daily Telegraph
Clean Financing Deal: Top Wall Street Bank Backs Alaunos While Major Investor PMGC Capital Demands Action - Stock Titan
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill - TipRanks
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Short Interest Update - Defense World
Juvenescence enhances AI drug discovery with Ro5 acquisition - Pharmaceutical Technology
Ziopharm: Q1 Earnings Snapshot - CT Insider
Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 2.4% – Time to Sell? - Defense World
PMGC Capital announces filing to report 5.09% stake in Alaunos Therapeutics - TipRanks
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. - GlobeNewswire
PMGC Capital Takes 5.09% Stake in Alaunos Therapeutics, Eyes Strategic Changes Including Fintech Expansion - Stock Titan
Alaunos Therapeutics Inc (TCRT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):